All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance
During the EHA2021 Virtual Congress, the MDS Hub spoke with Theo de Witte, Radboudumc, Nijmegen, NL. We asked, What are the highlights of EHA 2021?
Highlights of EHA 2021
In this video, de Witte outlines the highlights in MDS from EHA 2021. He gives an overview of studies investigating novel agents, such as sabatolimab and magrolimab. Finally, de Witte discusses new ways to look at myelodysplastic immune compositions, such as identification of immune cell subsets.
EHA2021 abstracts: what’s hot in myelodysplastic syndromes?
To help navigate the exciting content being presented at the EHA2021 Virtual Congress, the MDS Hub Steering Committee members have provided their recommendations for the top abstracts to...
What hematologic toxicities occur after venetoclax + azacitidine in MDS and how can they be managed?
During the EHA2021 Virtual Congress, the MDS Hub spoke with Vinod Pullarkat, City of Hope Comprehensive Cancer Center, Duarte, US. We asked, What...
Subscribe to get the best content related to MDS delivered to your inbox